Ligand binding assays were determined for compounds under study, at μ-, δ-, and κ-opioid receptors, as described in detail elsewhere [30,31]. Binding affinities for μ-, δ-, and κ-opioid receptors were determined by displacing, respectively, [3H]DAMGO (1 nM), [3H]DADLE (1 nM) and [3H]U69593 (1 nM) from mouse brain membrane binding sites. Brain membranes were incubated with the appropriate [3H]-ligand in 50 mM Tris–HCl buffer, pH 7.4, at 25 °C for 60 min in the absence or presence of 10 μM naloxone. IC50 values were determined from log dose displacement curves, and Ki values were calculated from the obtained IC50 values by means of the equation of Cheng and Prusoff [32].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.